Some researches thought Her-2 positive expression was due to the process of atypical hyperplasia in DCIS, but in developing into IDC Her-2 frequently lose, or Her-2 caused the direct immune response. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.